Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2841245 | 0.77 | — | — | |
| SCHEMBL27427767 | 0.74 | TSHR (0.41) | — | |
| Ethylamine SCHEMBL29241948 | 0.73 | TP53 (0.41) | TP53 | |
| Sulfuric Acid SCHEMBL28987947 | 0.72 | TP53 (0.40) | TP53 | |
| SCHEMBL9654286 | 0.72 | TP53 (0.40) | TP53 | |
| Hydrochloric Acid SCHEMBL30564937 | 0.72 | MAPT (0.40) | TP53 | |
| SCHEMBL23392536 | 0.71 | TP53 (0.33) | TP53 | |
| SCHEMBL4253570 | 0.70 | — | — | |
| SCHEMBL4252534 | 0.70 | — | — | |
| SCHEMBL28901 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9540389-B2 | Antimicrobial potentiators | MICROBIOTIX, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| US-20160075714-A1 | Antimicrobial Potentiators | MICROBIOTIX, INC. (US) | 2016-03-17 | — | — | US | disclosed |
| WO-2013052263-A2 | ANTIFUNGAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013040526-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040527-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040528-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2010056914-A1 | BACTERIAL HELICASE INHIBITOR COMPOUNDS AND USES THEREOF | MICROBIOTIX, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| EP-1406494-B1 | BACTERICIDAL COMPOSITION COMPRISING POLYLYSIN AND PLANT NATURAL OILS | KAO CORP (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-6921745-B2 | Bactericidal composition comprising polylysine and a plant essential oil | KAO CORPORATION (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040132630-A1 | Bactericide comoposition | KAO CORPORATION (JP) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075714-A1 | Antimicrobial Potentiators | NR1H2, ABCC5, NR1H3 | TP53 4677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.